Evoke Pharma
EVOK
EVOK
23 hedge funds and large institutions have $1.13M invested in Evoke Pharma in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.05% less ownership
Funds ownership: 0.09% → 0.04% (-0.05%)
79% less capital invested
Capital invested by funds: $5.46M → $1.13M (-$4.33M)
Holders
23
Holding in Top 10
–
Calls
$29K
Puts
$2K
Top Buyers
| 1 | +$25K | |
| 2 | +$20.4K | |
| 3 | +$8K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.3K |
| 5 |
BlackRock
New York
|
+$2.64K |
Top Sellers
| 1 | -$2.21M | |
| 2 | -$517K | |
| 3 | -$53.8K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$21K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.5K |